- Investopedia•15 hours ago
Tech stocks such as Facebook, Amazon and Alphabet are likely to rise in 2017.
- Barrons.com•3 days ago
Abbott Laboratories • ABT-NYSE Overweight • Price $40.74 on Jan. 9 by Barclays With the Jan. 4 close of Abbott’s acquisition of medical-device maker St. Jude Medical (STJ), we are updating our model to include both that purchase and recent divestitures (including Abbott medical optics and vascular units). For 2018, our EPS estimate has increased three cents, to $2.80, to reflect approximately 10% organic EPS growth and additional accretion from St. Jude of some 10 cents in earnings. In our view, Abbott shares have been dislocated by the noise around these deals and near deals, and we see this as a unique opportunity to buy a quality asset at a discount.
- Investor's Business Daily•5 days ago
Online travel remains a competitive, fragmented field where Priceline and Expedia continue to do well, says new analyst coverage at Credit Suisse.
EXPE : Summary for Expedia, Inc. - Yahoo Finance
Expedia, Inc. (EXPE)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
|Bid||118.51 x 300|
|Ask||119.27 x 300|
|Day's Range||117.81 - 120.44|
|52 Week Range||88.40 - 133.55|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||18.64|
|Dividend & Yield||1.04 (0.88%)|
|1y Target Est||N/A|